Merck unveils cutting-edge fertility technology in India

28 Feb 2019 Evaluate

Merck has unveiled its cutting-edge fertility technology in India. The business launched two devices, namely Geri and Gavi, as well as Gems, a complete culture medium suite. This will be made available in partnership with GeneaBiomedx, to IVF clinics and hospitals.

This new technology provides an environment that helps to reduce external stresses on the embryos of patients undergoing fertility treatment. Individually-controlled chambers allow the embryos of each patient to grow separately and real-time cameras attached to each chamber reduces the frequency of opening and closing the chambers in Geri. Not only does this allow observation of the progress of embryo growth without removing the embryo from the chamber, it also reduces the impact on the embryo of factors such as changes in gas concentration and temperature.

Merck is engaged in manufacturing and marketing of pharmaceuticals, bulk drugs, fine chemicals and pigments. The company operates through two segments - Pharmaceuticals and Chemicals.

Procter&Gamble Healt Share Price

4716.00 -20.35 (-0.43%)
25-Apr-2024 15:06 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1518.55
Dr. Reddys Lab 6210.65
Cipla 1407.90
Zydus Lifesciences 950.75
Lupin 1595.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.